TSE:NTLX Stock Latest News
Company AnnouncementsNeuroThera Labs Advances Phase IIb Tourette Trial With Key Manufacturing Milestone3w ago
Company AnnouncementsNeuroThera expands U.S. patent portfolio for PEA-psychedelic therapies1M ago
Company AnnouncementsNeuroThera Labs Seeks FDA Orphan Status for Tourette Drug, Hires RK Strategies2M ago
Company AnnouncementsNeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-2102M ago
Company AnnouncementsNeuroThera Labs to Consolidate Shares Ahead of Potential New Exchange Listings2M ago
Company AnnouncementsNeuroThera Labs Hires European IR Firm to Expand Investor Reach2M agoCompany AnnouncementsNeuroThera and Clearmind Secure U.S. Patent Milestone for MDMA-PEA PTSD Therapy2M ago
Company AnnouncementsNeuroThera Labs Raises C$2.7 Million in Final Tranche of Private Placement2M ago
Company AnnouncementsNeuroThera Labs Raises C$2.7 Million in First Tranche of Private Placement3M ago
Company AnnouncementsNeuroThera Labs Wins Japanese Patent for Next-Generation Pain and Fever Therapy3M ago
Company AnnouncementsNeuroThera Labs Expands Tourette Drug Trial to Yale in Phase IIb Study3M ago
Company AnnouncementsCI Global Asset Management Lowers Risk Ratings on Three Funds, Lifts One3M ago
Company AnnouncementsNeuroThera, Clearmind Advance Non-Hallucinogenic Depression Therapy With New Patent Filing8M agoCompany AnnouncementsNeuroThera and Clearmind Advance Patent for Obesity and Liver Disease Therapy8M ago
Company AnnouncementsNeuroThera Labs to Acquire Majority Stake in Quantum Clinical Trials Firm CliniQuantum8M ago
Company AnnouncementsNeurothera Labs Wins U.S. Patent for Cannabinoid-Antibiotic Platform Targeting MRSA9M ago
Company AnnouncementsNeurothera Labs Shareholders Approve Auditor, Share Consolidation Authorization and Equity Incentive Plan10M ago
Company AnnouncementsNeurothera Labs Wins Israeli Patent for Opioid-Sparing Pain Therapy Platform10M ago
Company AnnouncementsNeurothera Labs to Acquire Stake in Quantum Bio Data Company11M ago
Company AnnouncementsNeurothera Labs and Clearmind Medicine File Patent for Innovative Depression Treatment11M ago

